Thus, higher GDF15 levels in PLWH occurring independently of age may mirror the confluence of older PLWH with the prevalence of advanced age‐related metabolic comorbidities, such as NAFLD, and significantly raises the disease burden in PLWH. This evidence concerns the gene GDF15 and metabolic dysfunction-associated steatotic liver disease.